Expert NetworkExpert InterviewGUTS

Slingshot members are talking to an expert! The topic is:

Exploring the potential of Fractyl Health's lead drug candidate Rejuva, an adeno-associated virus (AAV)-based GLP-1 pancreatic gene therapy for obesity and type 2 diabetes

Executed on:Jul 19, 2024 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Mayo Clinic
  • Endocrinologist and part of the Mayo Clinic Precision Medicine for Obesity program
  • Treats over 1000 patients for obesity per year
  • Clinical and research focus on understanding obesity's pathophysiology to develop more effective therapeutic interventions, especially for perimenopausal women and breast cancer survivors.

Interview Goal

This conversation will examine the future of the weight management space and discuss the potential of a pancreatic GLP1 gene therapy and the early data presented by Fractyl Health

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.